BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27044827)

  • 1. Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma.
    Peng W; Wu J; Feng J
    Biomed Pharmacother; 2016 Apr; 79():188-93. PubMed ID: 27044827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma.
    Yan Y; Han J; Li Z; Yang H; Sui Y; Wang M
    Mol Med Rep; 2016 Jun; 13(6):5125-31. PubMed ID: 27122348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity.
    Peng W; Fan H; Wu G; Wu J; Feng J
    Clin Exp Med; 2016 May; 16(2):177-82. PubMed ID: 25864113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.
    Peng W; Wu J; Feng J
    Clin Exp Med; 2017 Feb; 17(1):1-8. PubMed ID: 26475621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma.
    Peng W; Feng J
    Biomed Pharmacother; 2016 Feb; 77():65-71. PubMed ID: 26796267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Elemene suppresses tumor growth of diffuse large B-cell lymphoma through regulating lncRNA HULC-mediated apoptotic pathway.
    Hu T; Gao Y
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation.
    Zhao Y; Guo Q; Chen J; Hu J; Wang S; Sun Y
    Oncol Rep; 2014 Jan; 31(1):358-64. PubMed ID: 24247585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
    Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
    Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma.
    Deng L; Jiang L; Tseng KF; Liu Y; Zhang X; Dong R; Lu Z; Wang X
    Cancer Biomark; 2018; 23(2):157-164. PubMed ID: 30175971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer.
    Peng W; Gao W; Feng J
    Med Oncol; 2014 Dec; 31(12):346. PubMed ID: 25412939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive analysis of long non-coding RNA expression profiles in diffuse large B-cell lymphoma.
    Zhu D; Fang C; Li X; Geng Y; Li R; Wu C; Jiang J; Wu C
    Oncotarget; 2017 Apr; 8(14):23228-23236. PubMed ID: 28423571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
    Meng H; Zhao B; Wang Y
    Exp Mol Pathol; 2020 Aug; 115():104451. PubMed ID: 32417392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA HULC promotes cell proliferation by regulating PI3K/AKT signaling pathway in chronic myeloid leukemia.
    Lu Y; Li Y; Chai X; Kang Q; Zhao P; Xiong J; Wang J
    Gene; 2017 Apr; 607():41-46. PubMed ID: 28069548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma.
    Verma A; Jiang Y; Du W; Fairchild L; Melnick A; Elemento O
    Genome Med; 2015 Nov; 7():110. PubMed ID: 26521025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients.
    Uzan VR; Lengert Av; Boldrini É; Penna V; Scapulatempo-Neto C; Scrideli CA; Filho AP; Cavalcante CE; de Oliveira CZ; Lopes LF; Vidal DO
    PLoS One; 2016; 11(6):e0156774. PubMed ID: 27253450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.
    Su Y; Sun B; Lin X; Zhao X; Ji W; He M; Qian H; Song X; Yang J; Wang J; Chen J
    Oncotarget; 2016 Aug; 7(31):49143-49155. PubMed ID: 27172795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis.
    Hu L; Zhao J; Liu Y; Liu X; Lu Q; Zeng Z; Zhu L; Tong X; Xu Q
    Int J Med Sci; 2020; 17(17):2735-2743. PubMed ID: 33162801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
    Sun XH; Yang LB; Geng XL; Wang R; Zhang ZC
    Int J Clin Exp Pathol; 2015; 8(3):2994-3000. PubMed ID: 26045809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA Highly Up-regulated in Liver Cancer Predicts Unfavorable Outcome and Regulates Metastasis by MMPs in Triple-negative Breast Cancer.
    Shi F; Xiao F; Ding P; Qin H; Huang R
    Arch Med Res; 2016 Aug; 47(6):446-453. PubMed ID: 27986124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expression.
    Yang XJ; Huang CQ; Peng CW; Hou JX; Liu JY
    Gene; 2016 Oct; 592(1):172-178. PubMed ID: 27496341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.